Lanperisone

{{Short description|Muscle relaxant drug}}

{{Infobox drug

| drug_name =

| IUPAC_name = (2R)-2-Methyl-3-(1-pyrrolidinyl)-1-[4-(trifluoromethyl)phenyl]-1-propanone

| image = Lanperisone skeletal.svg

| alt =

| caption =

| tradename =

| Drugs.com =

| MedlinePlus =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category=

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 116287-14-0

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = TO2JP2G53H

| ATCvet =

| ATC_prefix = None

| ATC_suffix =

| PubChem = 198707

| ChemSpiderID = 171991

| ChEBI = 176339

| ChEMBL = 1951050

| DrugBank =

| C = 15 | H = 18 | F = 3 | N = 1 | O = 1

| smiles = C[C@H](CN1CCCC1)C(=O)C2=CC=C(C=C2)C(F)(F)F

| StdInChI=1S/C15H18F3NO/c1-11(10-19-8-2-3-9-19)14(20)12-4-6-13(7-5-12)15(16,17)18/h4-7,11H,2-3,8-10H2,1H3/t11-/m1/s1

| StdInChIKey = RYZCWZZJFAKYHX-LLVKDONJSA-N

}}

Lanperisone (INN) is a muscle relaxant.{{cite journal | vauthors = Sakitama K, Ozawa Y, Aoto N, Tomita H, Ishikawa M | title = Effects of a new centrally acting muscle relaxant, NK433 (lanperisone hydrochloride) on spinal reflexes | journal = European Journal of Pharmacology | volume = 337 | issue = 2–3 | pages = 175–87 | date = October 1997 | pmid = 9430412 | doi = 10.1016/S0014-2999(97)01289-2 }}